Douglas Ernest Giordano is a businessperson who has been at the head of 6 different companies. Presently, he holds the position of Advisor at New Rhein Healthcare Investors, Chief Executive Officer for Anacor Pharmaceuticals LLC, President at Encysive Pharmaceuticals, Inc., President, Treasurer & Director at Array BioPharma, Inc., President & Director at FoldRx Pharmaceuticals LLC and Managing Director at Perceptive Advisors (Private Equity). Mr. Giordano is also Vice President at Icagen, Inc. and Member-Visitors Board at Duke University School of Medicine and on the board of 5 other companies.

In his past career he was Senior VP-Worldwide Business Development at Pfizer Inc. President at Serenex, Inc. and President, Treasurer & Director at Medivation LLC (California) (both are subsidiaries of Pfizer Inc.).

He received an undergraduate degree from Duke University and an MBA from Johnson Graduate School of Management.